Moral hazard and Non-transferable risk: Difference between pages

From ACT Wiki
(Difference between pages)
Jump to navigationJump to search
imported>Doug Williamson
(Add link.)
 
imported>Doug Williamson
(Create the page. Source: MCT reading 4.1.3, p12, 01 March 2012.)
 
Line 1: Line 1:
1.
Non-transferable risks are risks which must be borne by an organisation.  


A tendency of managers of large financial firms to take excessive risks, knowing (or expecting) that their business will be saved by the authorities.


Banking supervision reforms, including Basel III, are designed to reduce moral hazard of this kind.
Non-transferable risks might be avoided or accepted and retained or reduced as appropriate. In the case of non-transferable business risks (which by definition are not avoided) it is important that the firm has a distinctive competence in the relevant areas.  


For example, a pharmaceutical company's non-transferable risks would include the risk that failure to gain approval for use of a new drug means that the research and development costs have been wasted.


2.
The tendency of some insured individuals or businesses to take excessive risks, that they would not have taken if they had not been insured.
3.
The risk that a party has not entered into a contract in good faith, or has provided misleading information.
For example, an insured may attempt to take unfair advantage of an insurer or other guarantor by suppressing information relevant to the assessment of a risk, or by not acting in accordance with the terms of a policy.
UK pensions legislation contains a number of clauses specifically designed to reduce the risk of moral hazard.




== See also ==
== See also ==
* [[Agency risk]]
*[[Transferable risk]]
* [[Anti-selection]]
* [[Basel III]]
* [[Financial Stability Board]]
* [[Pension Protection Fund]]
* [[Too Big To Fail]]
 
[[Category:Manage_risks]]
[[Category:Risk_frameworks]]

Revision as of 08:16, 19 May 2015

Non-transferable risks are risks which must be borne by an organisation.


Non-transferable risks might be avoided or accepted and retained or reduced as appropriate. In the case of non-transferable business risks (which by definition are not avoided) it is important that the firm has a distinctive competence in the relevant areas.

For example, a pharmaceutical company's non-transferable risks would include the risk that failure to gain approval for use of a new drug means that the research and development costs have been wasted.


See also